Skip to content

The Role of Vitamin D Supplementation on Pain in Women With Primary Dysmenorrhea and Hypovitaminosis D

The Role of Vitamin D Supplementation on Pain in Women With Primary Dysmenorrhea and Hypovitaminosis D: A Randomized, Double-blind, Placebo-Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04829487
Enrollment
36
Registered
2021-04-02
Start date
2021-05-01
Completion date
2023-04-30
Last updated
2021-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypovitaminosis D

Brief summary

The purpose of this study is to evaluate the effect of vitamin D supplementation on the pain score of primary dysmenorrhea. Our hypothesis is that by normalizing vitamin D level could help improve pain score of women who have primary dysmenorrhea.

Detailed description

This study is aimed to be conducted in randomised controlled trial, comparing between intervention group and placebo group. We include women with primary dysmenorrhea who also have low vitamin D level in this trial. Our primary outcome is to compare visual analog pain scale between intervention and placebo group after treatment. After randomised and allocated, these women will be given vitamin D 50,000 IU or placebo capsules orally weekly for 8 consecutive weeks. We monitor pain score daily from the cycle before the drugs started until complete 8-week course of the regimen mentioned. Also vitamin D levels will be monitored twice, one before treatment and the other after treatment.

Interventions

Given to subjects 50,000 IU per week for 8 weeks

DRUGPlacebo

Placebo capsules

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Randomised controlled study

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Primary dysmenorrhea * Hypovitaminosis D

Exclusion criteria

* Using calcium, magnesium or phosphorus in the past 3 months * Using hormonal contraception or IUD in the past 6 months * No smoking or alcohol drinking * Chronic underlying diseases * Allergic to components in study drugs

Design outcomes

Primary

MeasureTime frameDescription
Visual analog pain scale8 weeksPain score between intervention and placebo group after treatment

Contacts

Primary ContactMananya Silpakit, Doctor
msilpakit@gmail.com+66987795945

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026